Top news of the week: 21.04.2020.
#COVID19 #CoronaVirus #pharmaceuticals #CoronaPandemic #biospace #lifesciences #CoronaOutbreak #biotechnology #biopharmaceutical #automate
Companies And Industries
Biopharma Update on the Novel Coronavirus: April 16
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/ShAvyG8EWM
OpenBiopharma Update on the Novel Coronavirus: April 16
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 16, 2020.
Biopharma Update on the Novel Coronavirus: April 14
#biospace #lifesciences #biotechnology #pharmaceuticals
#CoronaVirus #COVID19 #CoronaOutbreak #CoronaPandemic
https://t.co/WutGUDmo6S
OpenBiopharma Update on the Novel Coronavirus: April 14
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for April 14, 2020.
Beyond COVID-19: Biotech Beach Companies Reinvigorate Small Molecules, Cannabinoids and More https://t.co/4kaR9dRI51 https://t.co/E5dC9xF0JS
OpenBeyond COVID-19: Biotech Beach Companies Reinvigorate Small Molecules, Cannabinoids and More
The COVID-19 battle dominates the news, but it doesn’t constitute all the news. Here’s what several Southern California Biotech Beach companies are doing that you might have missed.
ICYMI: We implemented the @WatersCorporation UNIFI Scientific Information System to #automate and #streamline our glycan workflows and expand project capacity to meet growing demand in the #biopharmaceutical industry. https://t.co/qUYGb9X6FJ https://t.co/cI1RIR19qa
OpenCase Study | CMO/CDMO Automates Glycan Workflows to Increase Business Capacity
Case Study | CMO/CDMO Automates Glycan Workflows to Increase Business Capacity
Mylan crowns ex-CEO Coury as exec chairman as Upjohn merger drags on
With the coronavirus pandemic pausing FTC reviews and complicating supply chains, Mylan is flying a holding pattern on its megamerger with Pfizer's Upjohn unit and scrambling to deal with ...
Leo Pharma pens Oneness Biotech, Microbio Shanghai pact for skin and asthma drug https://t.co/QR06kj42df
OpenLeo Pharma pens Oneness Biotech, Microbio Shanghai pact for skin and asthma drug
Leo Pharma is paying $40 million upfront and $530 million in biobucks to license a midstage experimental eczema and asthma drug.
In the race to detect the deadly novel #coronavirus and treat #COVID19, a multinational group of top #scientists from government, the #biopharmaceutical industry and academia have banded together to battle a global disease that knows no borders. Learn more https://t.co/xDmOkUPwsF https://t.co/1NepqRFZfu
OpenA global health crisis inspires unique partnerships
In the race to detect and treat COVID-19, biotech, government and academia are joining forces to battle a disease that knows no borders.
RT @orasure: U.S. grant speeds this Pa. coronavirus test to market this year https://t.co/rfoEEMSsIO via @phillyinquirer
OpenU.S. grant speeds this Pa. coronavirus test to market this year
OraSure, a profitable Bethlehem company best known for its home test that finds HIV in spit, has collected a $700,000 grant from the federal BARDA agency to get its COVID-19 test approved ...